Masimo's family of continuous and spot-check monitoring Pulse CO-Oximeters ® includes devices designed for use in a variety of clinical and non-clinical scenarios, including tetherless, wearable ...

Masimo’s family of continuous and spot-check monitoring Pulse CO-Oximeters® includes devices designed for use in a variety of clinical and non-clinical scenarios, including tetherless ...

Masimo’s family of continuous and spot-check monitoring Pulse CO-Oximeters ® includes devices designed for use in a variety of clinical and non-clinical scenarios, including tetherless ...

Masimo Co. has a 52 week low of $101.61 and a 52 week high of $180.97. The company has a current ratio of 2.01, a quick ratio of 1.11 and a debt-to-equity ratio of 0.50. Want More Great Investing ...

After its longtime chief was ousted last year following a proxy battle, Masimo has now appointed a new CEO. | The medtech has ...

Szyman currently serves as the worldwide president of Advanced Patient Monitoring at Becton Dickinson and Co.

Masimo named Becton Dickinson executive Katie Szyman as its top boss, the medical device maker said on Tuesday, months after longtime CEO and founder Joe Kiani was ousted in a bitter proxy battle with ...

Masimo Co. has a 52-week low of $101.61 and a 52-week high of $180.97. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.11 and a current ratio of 2.01. Want More Great Investing ...

IRVINE, Calif., January 16, 2025--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI) today announced select preliminary financial results for the fourth quarter and full-year ended December 28 ...

Interim CEO Michelle Brennan Named Chairman of Masimo’s Board IRVINE, Calif., January 21, 2025--(BUSINESS WIRE)--Today the Board of Directors (the "Board") of Masimo (NASDAQ: MASI), a leading ...